Rewiring Relief | Breakthroughs Can't Wait
What if one of the most powerful ways to ease the side effects of cancer treatment didn’t come from a drug prescription, but from movement?That’s the focus of Ian Kleckner, PhD, MPH, associate professor and director of the Cancer Control Mind & Body Lab at the University of Maryland School of Nursing. A physicist-turned-psychologist and neuroscientist with a passion for understanding how the mind and body work together, Kleckner is studying how exercise can reduce the painful, long-lasting nerve symptoms caused by chemotherapy — known as chemotherapy-induced peripheral neuropathy.Backed by the National Institutes of Health and American Cancer Society, Kleckner’s lab uses methods from neuroscience, physiology, and behavioral science to examine how walking and resistance exercise can improve not only physical function, but also brain activity, balance, and mood in people with cancer. The lab’s work is grounded in his belief that the key to treating neuropathy lies not only in the nerves in the hands and feet, but in the brain’s ability to adapt and retrain the body.This spotlight is part of Breakthroughs Can’t Wait: Changing the Future Today, a campaign highlighting how federally funded research at the University of Maryland, Baltimore is driving health innovation.๐ Learn more about his research: https://www.umaryland.edu/breakthroughs
#BreakthroughsCantWait #NIHResearch #HealthInnovation #ExerciseScience #PainRelief #MentalHealthMatters #OncologyCare
More from Youtube
- 0:49Helping Babies Thrive from Day One | Breakthroughs Can’t WaitWhat if we could improve a baby’s health by being nurturing parents?At the University of Maryland, Baltimore, researchers are launching innovative programs to support maternal and infant health — helping Maryland’s babies get the strongest start possible.Lisa Berlin, PhD, MS, the Alison L. Richman Professor of Children and Families at the University of Maryland School of Social Work and expert in early child-caregiver attachment, is studying how a brief, home-based parenting program can make a measurable difference in children’s health and development. It's called the Attachment and Biobehavioral Catch-Up, or ABC Program.This is one of many ways NIH-funded research at UMB is tackling real-world health disparities and changing lives.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #MaternalHealth #InfantHealth #UMBResearch #NIHfunding #HealthEquity #PublicHealth
- 0:56Could Weight-Loss Drugs Curb Cravings for Addictive Substances? | Breakthroughs Can’t WaitEveryone has heard of Ozempic and Wegovy for treating diabetes and weight loss. But, what's been discovered in clinical trials, is an anti-craving effect is showing promising results for those battling alcohol and drug addiction.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 0:55Confronting the 4th Wave of the Drug Overdose Death Crisis | Breakthroughs Can't WaitOpioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 0:45Can a Weight-Loss Drug Help Treat Cocaine Addiction? | Breakthroughs Can’t WaitCan a weight-loss drug help treat cocaine addiction?At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 4:53Changing the Future of Addiction Care | Breakthroughs Can’t Wait with Dr. Sarah KattakuzhyCan a class of drugs best known for treating diabetes and weight loss also help people struggling with cocaine use disorder?Dr. Sarah Kattakuzhy, an associate professor at the University of Maryland School of Medicine, is leading innovative research on GLP-1 receptor agonists — medications that may offer a new path forward in treating addiction.This NIH-funded research could transform how we understand and address substance use, giving people more options — and more hope.๐งช Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.๐ Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #AddictionResearch #CocaineUseDisorder #GLP1 #SubstanceUseDisorder #UMBResearch #NIHfunding #HealthInnovation #DrSarahKattakuzhy
- 4:24UMB's 13th Annual Interprofessional Education DayHosted by the University of Maryland Baltimore's Center for Interprofessional Education (CIPE) on April 2, IPE Day brought together more than 170 students from all seven UMB professional schools — including medicine, nursing, pharmacy, law, dentistry, physical therapy, social work, and the Graduate School — for a full afternoon of collaborative learning, simulation activities, and real-life insights into the power of team-based care.Read more: https://www.umaryland.edu/news/archived-news/april-2025/ipe-day-centers-on-listening-to-patients-and-peers.php